HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tianqi Yu Selected Research

Arsenic

2/2019Chronic low dose arsenic exposure preferentially perturbs mitotic phase of the cell cycle.
1/2017Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].
1/2016Low doses of arsenic, via perturbing p53, promotes tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tianqi Yu Research Topics

Disease

7Neoplasms (Cancer)
01/2023 - 01/2016
6Infections
08/2021 - 07/2015
4Carcinogenesis
01/2022 - 01/2016
1Infertility (Sterility)
09/2022
1Female Infertility
09/2022
1Male Infertility (Male Sterility)
09/2022
1Orthomyxoviridae Infections
04/2020
1Colonic Neoplasms (Colon Cancer)
01/2018
1Viremia
07/2015

Drug/Important Bio-Agent (IBA)

3ArsenicIBA
02/2019 - 01/2016
2chromium hexavalent ionIBA
01/2022 - 01/2017
1Biomarkers (Surrogate Marker)IBA
01/2023
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
09/2022
1Fatty Acids (Saturated Fatty Acids)IBA
09/2022
1Monounsaturated Fatty AcidsIBA
09/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1Protein Kinase CIBA
01/2022
1Deubiquitinating EnzymesIBA
08/2021
1RNA (Ribonucleic Acid)IBA
04/2020
1Messenger RNA (mRNA)IBA
04/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Circular RNAIBA
04/2019
1Arsenicals (Arsenic Compounds)IBA
02/2019
1sodium arsenite (sodium metaarsenite)IBA
02/2019
1Hazardous Substances (Hazardous Materials)IBA
02/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Polysaccharides (Glycans)IBA
01/2018
1Irinotecan (Camptosar)FDA LinkGeneric
01/2018
1Cyclin EIBA
01/2018
1Topoisomerase InhibitorsIBA
01/2018
1Protein Isoforms (Isoforms)IBA
05/2017
1VaccinesIBA
07/2015

Therapy/Procedure

1Therapeutics
01/2019